From: Significant association between polymorphism of the erythropoietin gene promoter and myelodysplastic syndrome
AML
MDS (WHO)
RAEB-T
CMML
G/T, n (%)
86 (46.24)
10 (23.8)
27 (46.55)
6 (54.55)
T/T, n (%)
74 (39.78)
20 (45.45)
19 (32.76)
2 (18.18)
G/G, n (%)
26 (13.98)
14 (31.82)
12 (20.69)
3 (27.27)